SEC Form 4 · open-market trades
Insider trading tracker
When a CEO, director or 10% owner buys or sells their own company's stock on the open market, they must file a Form 4 with the SEC within two business days. Every one of those trades filed since 2026-10-22 is here, updated hourly. Buys by several insiders at once (cluster buys) are the ones investors watch most.
Trades
531
Insider buys
145
Buy value
$33.69M
Cluster buys (30d)
8
Cluster buys — several insiders buying (last 30 days)
Rapport Therapeutics, Inc.
5 insiders · 6 buys · latest 2026-10-23
Sanchez Ramiro, Paul Steven M, Maraganore John, Young Wendy B.
CITY HOLDING CO
4 insiders · 4 buys · latest 2026-10-23
Fisher Robert D, Strong-Treister Diane W, Hoyer James A, Reyes Javier A
Rent the Runway, Inc.
3 insiders · 3 buys · latest 2026-10-23
Nexus Capital Management LP, STORY3 Capital Partners, LLC, CHS US Investments LLC
NXG NextGen Infrastructure Income Fund
2 insiders · 2 buys · latest 2026-10-23
Swank Jerry V, Nelson Blake
BNY MELLON STRATEGIC MUNICIPALS, INC.
2 insiders · 3 buys · latest 2026-10-22
Saba Capital Management, L.P., Bank Of America Corp /De/
BNY MELLON STRATEGIC MUNICIPAL BOND FUND, INC.
2 insiders · 3 buys · latest 2026-10-22
Saba Capital Management, L.P., Bank Of America Corp /De/
U S GLOBAL INVESTORS INC
2 insiders · 2 buys · latest 2026-10-22
Gator Capital Management, LLC, Pilecki Derek Steven
Nuveen Municipal Credit Opportunities Fund
2 insiders · 3 buys · latest 2026-10-22
Jones Nathaniel T., Bank Of America Corp /De/
Showing ELV. Clear · Open ELV analysis
| Filed | Ticker | Insider | Title | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|---|
| 2026-10-23 | ELV Elevance Health, Inc. | Kaye Mark | EVP & CFO | SELL | 2,343 | $441.34 | $1.03M | SEC filing |
| 2026-10-23 | ELV Elevance Health, Inc. | Kaye Mark | EVP & CFO | SELL | 1,720 | $440.44 | $758K | SEC filing |
| 2026-10-23 | ELV Elevance Health, Inc. | Kaye Mark | EVP & CFO | SELL | 1,660 | $436.20 | $724K | SEC filing |
| 2026-10-23 | ELV Elevance Health, Inc. | Kaye Mark | EVP & CFO | SELL | 1,160 | $439.25 | $510K | SEC filing |
| 2026-10-23 | ELV Elevance Health, Inc. | Kaye Mark | EVP & CFO | SELL | 827 | $446.05 | $369K | SEC filing |
| 2026-10-23 | ELV Elevance Health, Inc. | Kaye Mark | EVP & CFO | SELL | 560 | $437.07 | $245K | SEC filing |
| 2026-10-23 | ELV Elevance Health, Inc. | Kaye Mark | EVP & CFO | SELL | 480 | $442.61 | $212K | SEC filing |
| 2026-10-23 | ELV Elevance Health, Inc. | Kaye Mark | EVP & CFO | SELL | 440 | $443.81 | $195K | SEC filing |
| 2026-10-23 | ELV Elevance Health, Inc. | Kaye Mark | EVP & CFO | SELL | 400 | $434.00 | $174K | SEC filing |
| 2026-10-23 | ELV Elevance Health, Inc. | Kaye Mark | EVP & CFO | SELL | 321 | $435.25 | $140K | SEC filing |
| 2026-10-23 | ELV Elevance Health, Inc. | Kaye Mark | EVP & CFO | SELL | 273 | $447.19 | $122K | SEC filing |
| 2026-10-23 | ELV Elevance Health, Inc. | Kaye Mark | EVP & CFO | SELL | 240 | $438.22 | $105K | SEC filing |
| 2026-10-23 | ELV Elevance Health, Inc. | Kaye Mark | EVP & CFO | SELL | 160 | $444.85 | $71K | SEC filing |
Source: SEC EDGAR Form 4 filings (open-market purchases and sales only; option exercises, gifts and grants excluded). Research only, not investment advice.